bexarotene

FDA Drug Profile — Targretin, bexarotene

Drug Details

Generic Name
bexarotene
Brand Names
Targretin, bexarotene
Application Number
NDA021056
Sponsor
Bausch Health US, LLC
NDC Codes
5
Dosage Forms
GEL, CAPSULE, LIQUID FILLED
Routes
TOPICAL, ORAL
Active Ingredients
BEXAROTENE

Indications and Usage

INDICATIONS AND USAGE Bexarotene gel, 1% is indicated for the topical treatment of cutaneous lesions in patients with CTCL (Stage IA and IB) who have refractory or persistent disease after other therapies or who have not tolerated other therapies.